Show simple item record

dc.contributor.authorScotece ., Morena
dc.contributor.authorConde Aranda, Javier
dc.date.accessioned2025-08-26T10:51:47Z
dc.date.available2025-08-26T10:51:47Z
dc.date.issued2022
dc.identifier.citationScotece M, Conde-Aranda J. Inflammation in Health and Disease: New Insights and Therapeutic Avenues. Vol. 23, International Journal of Molecular Sciences. 2022.
dc.identifier.issn1422-0067
dc.identifier.otherhttps://portalcientifico.sergas.gal/documentos/63824b558a8e8f467220221e*
dc.identifier.urihttp://hdl.handle.net/20.500.11940/20705
dc.description.sponsorshipThe research of JCA is funded by the Instituto de Salud Carlos III through the `Miguel Servet' Program and by the Fondo Social Europeo (FSE), CP19/00172 and PI21/00880.en
dc.language.isoeng
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleInflammation in Health and Disease: New Insights and Therapeutic Avenues*
dc.typeEditorial Materialen
dc.authorsophosScotece, J. M.
dc.authorsophosConde, Aranda
dc.identifier.doi10.3390/ijms23158392
dc.identifier.sophos63824b558a8e8f467220221e
dc.issue.number15
dc.journal.titleInternational Journal of Molecular Sciences*
dc.relation.projectIDInstituto de Salud Carlos III through the `Miguel Servet' Program; Fondo Social Europeo (FSE) [CP19/00172, PI21/00880]
dc.relation.publisherversionhttps://digital.csic.es/bitstream/10261/288865/1/Inflammation%20in%20health%20and%20disease_Scocete_PV_Art2022.pdf;https://mdpi-res.com/d_attachment/ijms/ijms-23-08392/article_deploy/ijms-23-08392.pdf?version=1659090480es
dc.rights.accessRightsopenAccess
dc.subject.keywordCHUACes
dc.subject.keywordAS Coruñaes
dc.subject.keywordINIBICes
dc.subject.keywordAS Santiagoes
dc.subject.keywordIDISes
dc.typefidesArtículo de Opinión (Editorial, Carta, ?)es
dc.typesophosArtículo de Opiniónes
dc.volume.number23


Files in this item

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
Except where otherwise noted, this item's license is described as Atribución 4.0 Internacional